Audentes Therapeutics - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Audentes Therapeutics M&A Summary

Audentes Therapeutics has acquired 1 company of its own.

Audentes Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Audentes Therapeutics Ownership

Who owns Audentes Therapeutics?

Audentes Therapeutics is owned by Astellas Pharma. It was acquired on December 2, 2019.

Audentes Therapeutics Business Overview

Where is Audentes Therapeutics headquartered?

Audentes Therapeutics is headquartered in San Francisco, California.

What is Audentes Therapeutics’ revenue?

Audentes Therapeutics disclosed revenue of 134M USD for 2018 and 93M USD for 2017.

How many employees does Audentes Therapeutics have?

Audentes Therapeutics has 207 employees.

What sector is Audentes Therapeutics in?

Audentes Therapeutics is a life science company.

When was Audentes Therapeutics founded?

Audentes Therapeutics was founded in 2012.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Audentes Therapeutics, Inc.

600 California Street, 17th Floor,
San Francisco, California 94108
United States,
(415) 818-1001
www.audentestx.com

Audentes Therapeutics, Inc. is a biotechnology company committed to the development and commercialization of innovative new treatments for people with serious, rare diseases through the application of AAV gene therapy technology. Audentes Therapeutics was founded in 2012 and is based in San Francisco, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Cardiogen Sciences, Inc. 2015-09-01 - Add-on Acquisition
Palo Alto, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  California 1 - - -
Total 1 - - -

 Subscribe to unlock this and 208,107
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.